Arterra Bioscience, Zeus Capital exceeds 5%

Arterra Bioscience Zeus Capital exceeds 5

(Tiper Stock Exchange) – Zeus Capital Alternative Sif has exceeded the significance threshold equal to 5% of the share capital of Arterra Biosciencea green biotech company specialized in research and development in the field of biotechnology and listed on Euronext Growth Milan.

In particular, the investment company holds 336,000 ordinary shares, equal to 5.05% of the share capital. Zeus Capital is now the fourth major shareholder of the Campania group.

tlb-finance